Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Lizee

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Journal (Sudbury, Mass.)|November 21, 2015
Endogenous T-Cell Therapy: Clinical ExperienceCassian Yee, Greg Lizee, Aaron J Schueneman
The Journal of Biological Chemistry|June 18, 2014
B-Raf regulation of integrin α4β1-mediated resistance to shear stress through changes in cell spreading and cytoskeletal association in T cellsWells S Brown, Jahan S Khalili, Tania G Rodriguez-Cruz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2023
Correction: IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in MelanomaShubhra Singh, Zhilan Xiao, Karishma Bavisi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2021
IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in MelanomaShubhra Singh, Zhilan Xiao, Karishma Bavisi, et al.
Journal for Immunotherapy of Cancer|December 25, 2024
High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLCMehmet Altan, Ruoxing Li, Ziyi Li, et al.
Research Square|June 29, 2026
Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinationsMinying Zhang, Barbara Nassif Rausseo, Peixin Jiang, et al.
Nature Communications|September 27, 2018
RNA editing derived epitopes function as cancer antigens to elicit immune responsesMinying Zhang, Jens Fritsche, Jason Roszik, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|November 21, 2015
Endogenous T-Cell Therapy: Clinical ExperienceCassian Yee, Greg Lizee, Aaron J Schueneman
The Journal of Biological Chemistry|June 18, 2014
B-Raf regulation of integrin α4β1-mediated resistance to shear stress through changes in cell spreading and cytoskeletal association in T cellsWells S Brown, Jahan S Khalili, Tania G Rodriguez-Cruz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2023
Correction: IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in MelanomaShubhra Singh, Zhilan Xiao, Karishma Bavisi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2021
IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in MelanomaShubhra Singh, Zhilan Xiao, Karishma Bavisi, et al.
Journal for Immunotherapy of Cancer|December 25, 2024
High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLCMehmet Altan, Ruoxing Li, Ziyi Li, et al.
Research Square|June 29, 2026
Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinationsMinying Zhang, Barbara Nassif Rausseo, Peixin Jiang, et al.
Nature Communications|September 27, 2018
RNA editing derived epitopes function as cancer antigens to elicit immune responsesMinying Zhang, Jens Fritsche, Jason Roszik, et al.
Pageof 1